A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer

Citation metadata

From: Cancer(Vol. 122, Issue 12)
Publisher: J.B. Lippincott Company
Document Type: Report

Document controls

Main content

Source Citation

Source Citation   

Gale Document Number: GALE|A458123325